Skip to main content

Oxygen Management in Neonatal Care

  • Chapter
  • First Online:
Emerging Topics and Controversies in Neonatology
  • 737 Accesses

Abstract

Most very preterm infants are treated with supplemental oxygen at some point in their clinical course before discharge home. The treatment is provided according to guidelines, and titrated according to measures of oxygenation with the aim of minimising harm, but uncertainties regarding the interpretation of the evidence have resulted in wide variation in practice. Recent evidence from randomised controlled trials now shows clearly that small differences in achieved oxygen saturation influence the risk of mortality and that practice trends favouring lower oxygen saturation targets in the hope of reducing retinopathy of prematurity or chronic lung disease are probably unsafe. Further research will be required to identify the optimal target range and to show whether or not servo control will improve outcomes. Outwith clinical trials, the best current evidence is to target the SpO2 range 91–95% for very preterm infants throughout their hospitalisation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 199.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Huch A, Huch R, Rooth G. Monitoring the intravascular PO2 in newborn infants. J Perinat Med. 1973;1:53–9.

    Article  CAS  Google Scholar 

  2. Bolton DP, Cross KW. Further observations on cost of preventing retrolental fibroplasia. Lancet. 1974;1:445–8.

    Article  CAS  Google Scholar 

  3. Bancalari E, Flynn J, Goldberg RN, et al. Influence of transcutaneous oxygen monitoring on the incidence of retinopathy of prematurity. Pediatrics. 1987;79:663–9.

    CAS  PubMed  Google Scholar 

  4. Flynn JT, Bancalari E, Snyder ES, et al. A cohort study of transcutaneous oxygen tension and the incidence and severity of retinopathy of prematurity. N Engl J Med. 1992;326(16):1050–4.

    Article  CAS  Google Scholar 

  5. American Academy of Pediatrics. Committee on Fetus and Newborn, ACOG Committee on Obstetrics. Maternal and fetal medicine. Guidelines for perinatal care. 2nd ed. American Academy of Pediatrics: Elk Grove Village; 1988.

    Google Scholar 

  6. American Academy of Pediatrics and the American College of Obstetricians and Gynecologists. Guidelines for perinatal care. 6th ed. American Academy of Pediatrics: Elk Grove Village; 2007.

    Google Scholar 

  7. Quine D, Stenson BJ. Arterial oxygen tension (PaO2) values in infants <29 weeks of gestation at currently targeted saturations. Arch Dis Child Fetal Neonatal Ed. 2009;94:F51–3.

    Article  CAS  Google Scholar 

  8. Tin W, Milligan DW, Pennefather P, Hey E. Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Archives of Disease in Childhood. Arch Dis Child Fetal Neonatal Ed. 2001;84:F106–10.

    Article  CAS  Google Scholar 

  9. Chow LC, Wright KW, Sola A, CSMC Oxygen Administration Study Group. Can changes in clinical practice decrease the incidence of severe retinopathy of prematurity in very low birth weight infants? Pediatrics. 2003;111:339–45.

    Article  Google Scholar 

  10. Anderson CG, Benitz WE, Madan A. Retinopathy of prematurity and pulse oximetry: a national survey of recent practices. J Perinatol. 2004;24:164–8.

    Article  Google Scholar 

  11. Silverman WA. A cautionary tale about supplemental oxygen: the albatross of neonatal medicine. Pediatrics. 2004;113:394–6.

    Article  Google Scholar 

  12. Supplemental therapeutic oxygen for prethreshold retinopathy of prematurity (STOP-ROP), a randomized, controlled trial. I: primary outcomes. Pediatrics. 2000;105:295–310.

    Google Scholar 

  13. Askie LM, Henderson-Smart DJ, Irwig L, Simpson JM. Oxygen-saturation targets and outcomes in extremely preterm infants. N Engl J Med. 2003;349:959–67.

    Article  CAS  Google Scholar 

  14. Balfour-Lynn IM, Field DJ, Gringras P, et al.; Paediatric Section of the Home Oxygen Guideline Development Group of the BTS Standards of Care Committee. BTS guidelines for home oxygen in children. Thorax. 2009;64 Suppl 2:ii1–26.

    Article  Google Scholar 

  15. Carlo WA, Finer NN, Walsh MC, et al.; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Target ranges of oxygen saturation in extremely preterm infants. N Engl J Med. 2010;362:1959–69.

    Google Scholar 

  16. Vaucher YE, Peralta-Carcelen M, Finer NN, et al.; SUPPORT Study Group of the Eunice Kennedy Shriver NICHD Neonatal Research Network. Neurodevelopmental outcomes in the early CPAP and pulse oximetry trial. N Engl J Med. 2012;367:2495–2504.

    Google Scholar 

  17. Schmidt B, Whyte RK, Asztalos EV, et al.; Canadian Oxygen Trial (COT) Group. Effects of targeting higher vs lower arterial oxygen saturations on death or disability in extremely preterm infants: a randomized clinical trial. JAMA. 2013;309:2111–20.

    Article  CAS  Google Scholar 

  18. BOOST II United Kingdom Collaborative Group, BOOST II Australia Collaborative Group, BOOST II New Zealand Collaborative Group, Stenson BJ, Tarnow-Mordi WO, Darlow BA, et al. Oxygen saturation and outcomes in preterm infants. N Engl J Med. 2013;368:2094–104.

    Article  Google Scholar 

  19. Darlow BA, Marschner SL, Donoghoe M, et al. Randomized controlled trial of oxygen saturation targets in very preterm infants: two year outcomes. J Pediatr. 2014;165:30–35.e2.

    Article  Google Scholar 

  20. BOOST-II Australia and United Kingdom Collaborative Groups, Tarnow-Mordi W, Stenson B, Kirby A, et al. Outcomes of two trials of oxygen-saturation targets in preterm infants. N Engl J Med. 2016;374:749–60.

    Article  Google Scholar 

  21. Askie LM, Brocklehurst P, Darlow BA, et al. NeOProM: Neonatal Oxygenation Prospective Meta-analysis Collaboration study protocol. BMC Pediatr. 2011;11:6.

    Article  Google Scholar 

  22. Askie LM, Darlow BA, Finer N, et al.; for the NeOProM Collaborators. Association between oxygen saturation targeting and death or disability in extremely preterm infants in the Neonatal Oxygenation Prospective Meta-analysis Collaboration. JAMA. 2018;319(21):2190–2201.

    Article  CAS  Google Scholar 

  23. Walsh MC, Yao Q, Gettner P, et al. Impact of a physiologic definition on bronchopulmonary dysplasia rates. Pediatrics. 2004;114:1305–11.

    Article  Google Scholar 

  24. Quine D, Wong CM, Boyle EM, Jones JG, Stenson BJ. Non-invasive measurement of reduced ventilation: perfusion ratio and shunt in infants with bronchopulmonary dysplasia: a physiological definition of the disease. Arch Dis Child Fetal Neonatal Ed. 2006;91:F409–14.

    Article  CAS  Google Scholar 

  25. Walsh MC, Di Fiore JM, Martin RJ, Gantz M, Carlo WA, Finer N. Association of oxygen target and growth status with increased mortality in small for gestational age infants: further analysis of the surfactant, positive pressure and pulse oximetry randomized trial. JAMA Pediatr. 2016;170:292–4.

    Article  Google Scholar 

  26. Kramer MS, Platt RW, Wen SW, et al. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics. 2001;108(2):E35.

    Article  CAS  Google Scholar 

  27. Alexander GR, Himes JH, Kaufman RB, Mor J, Kogan M. A United States national reference for fetal growth. Obstet Gynecol. 1996;87(2):163–8.

    Article  CAS  Google Scholar 

  28. Johnston ED, Boyle B, Juszczak E, King A, Brocklehurst P, Stenson BJ. Oxygen targeting in preterm infants using the Masimo SET radical pulse oximeter. Arch Dis Child Fetal Neonatal Ed. 2011;96:F429–33.

    Article  Google Scholar 

  29. Stenson BJ, Donoghoe M, Brocklehurst P, et al. SpO2 targeting and oximeter changes in the BOOST-II Australia and BOOST-II UK oxygen trials. J Pediatr. 2019;204:301–304.e2.

    Article  Google Scholar 

  30. Askie LM, Darlow BA, Davis PG, et al. Effects of targeting lower versus higher arterial oxygen saturations on death or disability in preterm infants. Cochrane Database Syst Rev. 2017;4:CD011190.

    PubMed  Google Scholar 

  31. Freemantle N, Calvert M, Wood J, Eastaugh J, Griffin C. Composite outcomes in randomized trials: greater precision but with greater uncertainty? JAMA. 2003;289:2554–9.

    Article  Google Scholar 

  32. Schmidt B, Roberts RS, Davis PG, et al. Prediction of late death or disability at age 5 years using a count of 3 neonatal morbidities in very low birth weight infants. J Pediatr. 2015;167:982–6.e2.

    Article  Google Scholar 

  33. Hagadorn JI, Furey AM, Nghiem TH, et al.; AVIOx Study Group. Achieved versus intended pulse oximeter saturation in infants born less than 28 weeks’ gestation: the AVIOx study. Pediatrics. 2006;118:1574–82.

    Article  Google Scholar 

  34. Jones JG, Lockwood GG, Fung N, et al. Influence of pulmonary factors on pulse oximeter saturation in preterm infants. Arch Dis Child Fetal Neonatal Ed. 2016;101:F319–22.

    Article  CAS  Google Scholar 

  35. van Kaam AH, Hummler HD, Wilinska M, et al. Automated versus manual oxygen control with different saturation targets and modes of respiratory support in preterm infants. J Pediatr. 2015;167:545–50.e1–2.

    Article  Google Scholar 

  36. Di Fiore JM, Martin RJ, Li H, et al; SUPPORT Study Group of the Eunice Kennedy Shriver National Institute of Child Health, and Human Development Neonatal Research Network. Patterns of oxygenation, mortality, and growth status in the surfactant positive pressure and oxygen trial cohort. J Pediatr. 2017;186:49–56.e1.

    Google Scholar 

  37. Cummings JJ, Polin RA; Committee on Fetus And Newborn. Oxygen targeting in extremely low birth weight infants. Pediatrics. 2016;138. pii: e20161576.

    Google Scholar 

  38. Sweet DG, Carnielli V, Greisen G, et al. European consensus guidelines on the management of respiratory distress syndrome—2016 update. Neonatology. 2017;111:107–25.

    Article  CAS  Google Scholar 

  39. Stenson B, Saugstad OD. Oxygen treatment for immature infants beyond the delivery room: lessons from randomized studies. J Pediatr. 2018;200:12–8.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ben Stenson .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Stenson, B. (2020). Oxygen Management in Neonatal Care. In: Boyle, E., Cusack, J. (eds) Emerging Topics and Controversies in Neonatology. Springer, Cham. https://doi.org/10.1007/978-3-030-28829-7_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-28829-7_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-28828-0

  • Online ISBN: 978-3-030-28829-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics